Patent details

Basic Information

Publication number:

EP1309334

PCT Application Number:

PCT/CA/2001/001055

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019537273

PCT Publication Number:

WO/2002/011742

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY USING REOVIRUS AND ANTI-ANTIREOVIRUS ANTIBODIES FOR THE TREATMENT OF RAS-MEDIATED PROLIFERATIVE DISORDERS

French Title of Invention:

THERAPIE COMBINATOIRE UTILISANT DES REOVIRUS ET DES ANTICORPS ANTI-ANTIREOVIRUS POUR LE TRAITEMENT DES DESORDRES PROLIFERATIFS MEDIES PAR RAS

German Title of Invention:

KOMBINATIONSTHERAPIE MITTELS REOVIRUS UND ANTI-ANTIREOVIRUS ANTIKÖRPERN ZUR BEHANDLUNG VON RAS-VERMITTELTEN, PROLIFERATIVEN ERKRANKUNGEN

SPC Number:

Dates

Filing date:

20/07/2001

Grant date:

11/02/2009

EP Publication Date:

11/02/2009

PCT Publication Date:

14/02/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/05/2003

EP B1 Publication Date:

11/02/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

20/07/2009

Expiration date:

20/07/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/07/2001

 

 

Name:

Oncolytics Biotech Inc.

Address:

Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7, Canada (CA)

Inventor

1

Name:

THOMPSON Bradley, G.

Address:

Canada (CA)

2

Name:

COFFEY Matthew, C.

Address:

Canada (CA)

Priority

Priority Number:

636597

Priority Date:

02/01/1991

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 35/76;

Filing date	Document type	Number of pages